Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) → HCID 86676364, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C@H:8]2[C@H:13]([C:14]([OH:16])=O)[CH2:12][CH2:11][N:10]([CH2:17][CH2:18][C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)[CH2:9]2)=[CH:4][CH:3]=1.[Cl:25][C:26]1[CH:34]=[CH:33][C:29]([C:30]([NH2:32])=[S:31])=[CH:28][CH:27]=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>C(Cl)Cl.CN(C1C=CN=CC=1)C>[Cl:25][C:26]1[CH:34]=[CH:33][C:29]([C:30]([NH:32][C:14]([C@@H:13]2[CH2:12][CH2:11][N:10]([CH2:17][CH2:18][C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)[CH2:9][C@H:8]2[C:5]2[CH:6]=[CH:7][C:2]([F:1])=[CH:3][CH:4]=2)=[O:16])=[S:31])=[CH:28][CH:27]=1Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of (3R*,4R*)-3-(4-fluorophenyl)-1-phenethyl-piperidine-4-carboxylic acid (50 mg, 0.137 mmol, prepared according to the procedure disclosed in WO 2002/068387) and 4-chlorothiobenzamide (28.3 mg, 0.165 mmol) in CH2Cl2 (1.0 ml) was treated with HBTU (62.5 mg, 0.165 mmol) and DMAP (10 mg, 0.082 mmol) at rt. The mixture was stirred at rt for 6 h and then concentrated. The resulting residue was purified by RP-HPLC(C18, water, acetonitrile, 0.05% TFA) to afford the title compound, which was contaminated with 4-chlorothiobenzamide and was used in the next step without further purification. HPLC/MS: 481.3, 483.1 (M+1); Rt=1.14 (LC-2 HPLC conditions).
Workup
- customprepared
- concentrationconcentrated
- customThe resulting residue was purified by RP-HPLC(C18, water, acetonitrile, 0.05% TFA)
Sources & evidence
- ORD record
- ord-2a2b5844ed6144bd942891d819036e0d
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08921394B2
Reaction notes
Loading…